Nivolumab Gets Additional Adjuvant Indication for Bladder Cancer Nivolumab Gets Additional Adjuvant Indication for Bladder Cancer
A potential new standard of care?FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 23, 2021 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Alert Source Type: news
English may miss out on new drug for bladder cancer
Married father-of-two Guy Heath (pictured) was told he could have just weeks to live, but after taking avelumab he feels he is now getting back to his old self. (Source: the Mail online | Health)
Source: the Mail online | Health - August 14, 2021 Category: Consumer Health News Source Type: news
Bladder cancer: The uncomfortable pain indicating your risk to the deadly disease
BLADDER cancer: When bladder tumours grow larger, or cancer cells spread to other areas of the body, they may cause symptoms including an inability to urinate or weakness and fatigue. Pain felt on a certain body part may also indicate your risk. (Source: Daily Express - Health)
Source: Daily Express - Health - August 12, 2021 Category: Consumer Health News Source Type: news
Women voice frustration over current care for recurrent urinary tract infections
This study really gave us insight into the patient perspective and showed us those with recurrent UTIs are dissatisfied with the current management of the condition. Continued episodes can have a major impact on their quality of life.”More than half of women will develop a UTI at some point, and roughly 1 in 4 will have repeat infections that can last for years. Many with recurrent infections will be prescribed antibiotics frequently over their lifetime.The researchers conducted focus groups with 29 women with recurrent UTIs — defined as two infections in six months or three in a year. Participants were asked about the...
Source: UCLA Newsroom: Health Sciences - August 4, 2021 Category: Universities & Medical Training Source Type: news
FDA Grants Orphan Drug Designation to Novel Mesothelioma Treatment
The U.S. Food and Drug Administration has granted orphan drug designation to ONCOFID-P for the treatment of malignant pleural mesothelioma, a step toward another potential therapy option for patients.
ONCOFID-P is an innovative drug conjugate already in advanced clinical development for the treatment of invasive bladder cancer. The mesothelioma designation is based on preclinical data showing high antitumor activity in laboratory and mice models.
Fidia Farmaceutici, a multinational research company based in Italy, announced the latest FDA designation, which is designed to encourage the development of novel drugs, par...
Source: Asbestos and Mesothelioma News - July 28, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news
Advanced bladder cancers respond to immunotherapy regardless of gene mutation status
(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger researchers and colleagues report a study has demonstrated that patients with advanced bladder cancers whose tumors have a mutated FGFR3 gene respond to immunotherapy in a manner that is similar to patients without that mutation. This discovery runs counter to previous research that suggested FGFR3-mutated bladder cancers should not be treated with immunotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 22, 2021 Category: Cancer & Oncology Source Type: news
New Drug Combination Shows Promise for Peritoneal Mesothelioma
Researchers at MD Anderson Cancer Center in Houston have uncovered a new, promising treatment option for patients with peritoneal mesothelioma, potentially filling a gaping void that exists today.
The immunotherapy drug combination of Tecentriq and Avastin, known generically as atezolizumab and bevacizumab, respectively, showed unusual efficacy in a recent study of 20 patients with this rare cancer.
Although some patients have previously found significant success and extended survival with the cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combination, or HIPEC, those with unresectable disease ha...
Source: Asbestos and Mesothelioma News - July 21, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news
Undone Proteins Take Out Bladder Cancer
An unfolded protein found in human milk shows promise in early clinical trials to treat bladder cancer. (Source: The Scientist)
Source: The Scientist - July 20, 2021 Category: Science Tags: Sponsored Article Source Type: news
First in Human Procedure with Vessi Medical's Cryotherapy System for Bladder Cancer
MISGAV, Israel, July 14, 2021 -- (Healthcare Sales & Marketing Network) -- Vessi Medical ("Vessi"), announced that it successfully completed a first-in-human case with its minimally invasive cryoablation solution for superficial bladder cancer ... Devices, Urology, Oncology Vessi Medical, cryoablation, bladder cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 14, 2021 Category: Pharmaceuticals Source Type: news
Cancer symptoms: Seven common warning signs of a growing tumour in the prostate
CANCEROUS cells that are pushing up against the urethra - the tube that carries urine from the bladder out through the tip of the penis - will cause bodily sensations. (Source: Daily Express - Health)
Source: Daily Express - Health - July 11, 2021 Category: Consumer Health News Source Type: news
Oncotarget: Urine RNA reveal tumor markers for human bladder cancer
(Impact Journals LLC) This Oncotarget work strongly suggests exploiting urine RNAs as diagnostic markers of bladder cancer and it suggests specific novel markers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 9, 2021 Category: Cancer & Oncology Source Type: news
Carbogen and Nicotinamide With Radiation Feasible for Bladder Cancer
THURSDAY, July 8, 2021 -- The use of concurrent carbogen and nicotinamide (CON) with radiation therapy is feasible for patients with muscle invasive bladder cancer (MIBC) in the Australian setting, according to a study published online June 30 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 8, 2021 Category: Pharmaceuticals Source Type: news
Nicotine by-product can predict recurrence of cancer
(European Association of Urology) A by-product of nicotine, found in the urine of smokers, could be used to identify when bladder cancer has returned, new research has found. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 8, 2021 Category: Cancer & Oncology Source Type: news
Aging-related conditions increase treatment burden in older cancer patients
(Geisinger Health System) Having multiple chronic health conditions and living in a rural area were the top two factors affecting increased healthcare system contact among older patients with bladder cancer, a research team has found. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2021 Category: Cancer & Oncology Source Type: news
New model aims to promote better-adapted bladder cancer treatment in the future
(Uppsala University) Uppsala University scientists have designed a new mouse model that facilitates study of factors contributing to the progression of human bladder cancer and of immune-system activation when the tumour is growing. Using this model, they have been able to study how proteins change before, while and after a tumour develops in the bladder wall. The study has now been published in the scientific journal PLOS ONE. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2021 Category: Cancer & Oncology Source Type: news
